文献速递乳腺MR

多参数MRI联合DCE与DWI在非肿块强化乳腺肿瘤中价值有限

Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors.
PubMed 文献 · Eur J Radiol · 2022-09-15

回顾性纳入66例DCE-MRI表现为可疑非肿块强化(BI-RADS 4/5)并接受影像引导活检的患者,评估DCE-MRI、DWI及四种mpMRI判读策略的诊断效能。DCE-MRI单独诊断乳腺癌敏感度最高(94.8-100%),优于所有mpMRI策略和DWI单独,mpMRI对NME的附加诊断价值有限。

要点

  • DCE-MRI单独对非肿块强化乳腺癌敏感度最高(94.8-100%),是评估NME的首选序列。
  • 联合DWI的mpMRI各判读策略敏感度均低于DCE-MRI单独,附加价值有限。
  • 基于BI-RADS分级的Adapted ADC阈值策略特异度最高(85.1%),但准确度因读者而异。
英文原文(摘要)· 点击展开

PURPOSE: To investigate the diagnostic value of multiparametric MRI (mpMRI) including dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI) in non-mass enhancing breast tumors.

METHOD: Patients who underwent mpMRI, who were diagnosed with a suspicious non-mass enhancement (NME) on DCE-MRI (BI-RADS 4/5), and who subsequently underwent image-guided biopsy were retrospectively included. Two radiologists independently evaluated all NMEs, on both DCE-MR images and high-b-value DW images. Different mpMRI reading approaches were evaluated: 1) with a fixed apparent diffusion coefficient (ADC) threshold (<1.3 malignant, ≥1.3 benign) based on the recommendation by the European Society of Breast Imaging (EUSOBI); 2) with a fixed ADC threshold (<1.5 malignant, ≥1.5 benign) based on recently published trial data; 3) with an ADC threshold adapted to the assigned BI-RADS classification using a previously published reading method; and 4) with individually determined best thresholds for each reader.

RESULTS: The final study sample consisted of 66 lesions in 66 patients. DCE-MRI alone had the highest sensitivity for breast cancer detection (94.8-100 %), outperforming all mpMRI reading approaches (R1 74.4-87.1 %, R2 71.7-94.8 %) and DWI alone (R1 74.4 %, R2 79.4 %). The adapted approach achieved the best specificity for both readers (85.1 %), resulting in the best diagnostic accuracy for R1 (86.5 %) but a moderate diagnostic accuracy for R2 (77.2 %).

CONCLUSION: mpMRI has limited added diagnostic value to DCE-MRI in the assessment of NME.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Marino, Avendano, Sevilimedu, et al. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors. Eur J Radiol. 2022. PMID: 36122521. doi:10.1016/j.ejrad.2022.110523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。